Retraction

The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis

Paper Information

Record ID:
52721
Publication Date:
February 17, 2023
Retraction Date:
February 20, 2024 (1.7 year years ago)
Article Type:
Publisher:
Frontiers
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (7)

7
Total Citations
3
Post-Retraction
(42.9%)
3
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
0 After 2+ years
226 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Efficacy and safety of anlotinib for triple-negative breast cancer with brain metastases
Zeyu Liu, Ming Li, Ziyi Zhao et al. (5 authors)
Frontiers in Oncology Open Access
Published: Oct 2024
226 days after retraction
Anlotinib plus Temozolomide for Recurrent Glioma: A Single-Center, Retrospective Study of 30 cases
Liping Xu, Dandan Yu, Fei Li et al. (7 authors)
Research Square (Research Square) Open Access
Published: May 2024
90 days after retraction
Safety and Efficiency of Anlotinib in Patients with Recurrent Grade 4 Glioma: A Single-Center Retrospective Analysis
Qiang Wang, Wuting Wei, Xiangjun Ji et al. (9 authors)
Neurology India
Published: May 2024
71 days after retraction
A MRI-based radiomics model for predicting the response to anlotinb combined with temozolomide in recurrent malignant glioma patients
Yurong Li, Weilin Xu, Yinjiao Fei et al. (11 authors)
Discover Oncology Open Access
Published: Aug 2023
5 citations
181 days before retraction
Safety and efficacy of anlotinib hydrochloride capsules in advanced non-small-cell lung cancer: a multicenter, real-world study
Meng Wang, Meng-Xia Mao, Yonghua Yang et al. (8 authors)
Future Oncology
Published: Aug 2023
1 citation
203 days before retraction
Catequentinib
Unknown Authors
Reactions Weekly
Published: Apr 2023
298 days before retraction
Quick Stats
Total Citations: 10
Years Since Retraction: 1.7 year
Open Access: Yes
Last Checked: Jul 24, 2025